Inaba Hidefumi, Ariyasu Hiroyuki, Iwakura Hiroshi, Ueda Yoko, Kurimoto Chiaki, Uraki Shinsuke, Takeshima Ken, Yamaoka Hiroyuki, Furukawa Yasushi, Morita Shuhei, Nishi Masahiro, Akamizu Takashi
The First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Clin Endocrinol (Oxf). 2019 Dec;91(6):786-792. doi: 10.1111/cen.14082. Epub 2019 Sep 12.
Adult-onset idiopathic isolated adrenocorticotropic hormone deficiency (id-IAD) is a rare disease with unknown aetiology. Recently, numerous cases of anti-PD-1 antibody-induced IAD (PD1-IAD) have been reported, but the clinical course, predictive factors and relationship to id-IAD have not been clarified. Moreover, associations of id-IAD and PD1-IAD with human leucocyte antigen (HLA) require elucidation.
Clinical characteristics of 13 Japanese patients with id-IAD and eight Japanese patients with PD1-IAD were analysed, and HLA-typing test was performed for each patient. Allele and haplotype frequencies of the patients were compared to those of healthy Japanese controls.
In the HLA allele and haplotype analyses of id-IAD, the frequencies of HLA-C14:02, HLA-DPB105:01, HLA-DRB104:05-DQB104:01-DPB105:01 and HLA-DRB109:01-DQB103:03-DPB105:01 were significantly increased. On the other hand, HLA alleles account for PD1-IAD susceptibility as follows: HLA-DQB106:01, HLA-DPB109:01 and HLA-DRB501:02. Moreover, protective effect for HLA-C03:03 was suggested in combined id-IAD and PD1-IAD patients. Comparison of the effects of HLA on id-IAD and PD1-IAD revealed some differences. Alleles or haplotypes frequencies increased in id-IAD group were as follows: HLA-DPB105:01, HLA-DRB109:01, HLA-DRB401:03:02, HLA-DQB103:03 and HLA-DRB109:01-DQB103:03. In clinical settings, hyponatremia, disturbance of consciousness and hypoglycaemia were less frequently seen in patients with PD1-IAD than in patients with id-IAD.
Distinct clinical characteristics and predisposing HLA allele contributions were proposed between id-IAD and PD1-IAD. Further investigations with greater number of cases are warranted to clarify the detailed mechanisms of id-IAD and PD1-IAD.
成人起病的特发性孤立性促肾上腺皮质激素缺乏症(id-IAD)是一种病因不明的罕见疾病。最近,已有许多抗程序性死亡蛋白1(PD-1)抗体诱导的IAD(PD1-IAD)病例报道,但临床病程、预测因素以及与id-IAD的关系尚未阐明。此外,id-IAD和PD1-IAD与人类白细胞抗原(HLA)的关联也需要阐明。
分析了13例日本id-IAD患者和8例日本PD1-IAD患者的临床特征,并对每位患者进行了HLA分型检测。将患者的等位基因和单倍型频率与健康日本对照者的进行比较。
在id-IAD的HLA等位基因和单倍型分析中,HLA-C14:02、HLA-DPB105:01、HLA-DRB104:05-DQB104:01-DPB105:01和HLA-DRB109:01-DQB103:03-DPB105:01的频率显著增加。另一方面,HLA等位基因对PD1-IAD易感性的影响如下:HLA-DQB106:01、HLA-DPB109:01和HLA-DRB501:02。此外,在合并id-IAD和PD1-IAD的患者中,提示HLA-C03:03具有保护作用。HLA对id-IAD和PD1-IAD影响的比较显示出一些差异。id-IAD组中增加的等位基因或单倍型频率如下:HLA-DPB105:01、HLA-DRB109:01、HLA-DRB401:03:02、HLA-DQB103:03和HLA-DRB109:01-DQB103:03。在临床情况下,PD1-IAD患者低钠血症、意识障碍和低血糖的发生率低于id-IAD患者。
提出了id-IAD和PD1-IAD之间不同的临床特征和易患HLA等位基因贡献。需要进行更多病例的进一步研究以阐明id-IAD和PD1-IAD的详细机制。